Tellgen Life Sciences' Six Medical Device Registration Applications Accepted by Shanghai Medical Products Administration

Regulation
โดย CLS·CN·Read original
Summary · why it matters

Tellgen Life Sciences announced that six medical device registration applications submitted by the company and its controlling subsidiary Maishi Biotech have been accepted by the Shanghai Medical Products Administration. The six applications include four Alzheimer's disease auxiliary diagnostic kits and two mass spectrometry detection kits. The above products are still in the registration application acceptance stage and will not have an impact on recent performance.

Impact on stocks 1

Others · 1 stocks
Tellgen Corp
300642
± MixedRegulationrelevance

Registration applications accepted, but no approval yet and no near-term impact.

Off-coverage companies 1

脉示生物Private± Mixed
Regulationrelevance

Subsidiary's applications accepted, but no approval yet and no near-term impact.